Lithium as a disease-modifying agent for prion diseases

Prion diseases still remain incurable despite multiple efforts to develop a treatment. Therefore, it is important to find strategies to at least reduce the symptoms. Lithium has been considered as a neuroprotective agent for years, and the objective of this preclinical study was to evaluate the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Relaño-Ginés, A., Lehmann, S., Brillaud, E., Belondrade, M., Casanova, D., Hamela, C., Vincent, C., Poupeau, S., Sarniguet, J., Alvarez, T., Arnaud, J. D., Maurel, J. C., Crozet, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105724/
https://www.ncbi.nlm.nih.gov/pubmed/30135493
http://dx.doi.org/10.1038/s41398-018-0209-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105724/
https://www.ncbi.nlm.nih.gov/pubmed/30135493
http://dx.doi.org/10.1038/s41398-018-0209-4

Ejemplares similares